Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised 
OpenAI Tightens AI Safety Monitoring After Security Incidents 
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI 
Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate 
Shein Targets $26B-$27B Valuation for Hong Kong IPO 
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut 
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook 
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case 
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside 
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows 
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push 
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth 
Google to Move All Pixel Production Out of China by 2027 
Coty Revenue Beats Estimates as Beauty Demand Holds Firm 
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts 
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits 
Add as a preferred source on Google
SK Telecom Co. has released a mobile app-based DNA testing service dubbed care8 DNA in partnership with its joint venture Invites Healthcare Co. and bio firm Macrogen Inc.
The subscription-based setting allows users to sign up for 29 types of genetic testing, such as for nicotine reliance and hair loss.
Users will receive DNA test kits at home, which they would send back to SK Telecom with their saliva for analysis.
Test results will be available on the care8 DNA app after two weeks.
According to SK Telecom, their DNA service, which costs 99,000 won for a one-year subscription, is more affordable than local direct-to-consumer (DTC) genetic tests.
The app also provides other services, such as personalized health coaching. More genetic tests would also be introduced.
SK Telecom, South Korea's largest mobile carrier, increased its investment in Israel-based startup Nano-X Imaging Ltd in June to boost its presence in the digital health care sector.
The global DTC genetic testing market is expected to increase to $6.4 billion in 2028 from $824 million in 2018.
